PODD's Q3 earnings and revenues top forecasts, with strong Omnipod growth and margin expansion lifting shares.

Insulet Corporation (NASDAQ: PODD), best known for its Omnipod insulin delivery system, is emerging as a compelling ...

Insulet reported Omnipod revenue of $699.2 million for the third quarter of 2025, up 31% over the same quarter in 2024 ...

Insulet is Thursday's IBD Stock Of The Day. After a wild post-earnings reaction, Insulet stock is in a consolidation with an ...

Countless hours of sleep, 10 years of her memory and the life of her 13-year-old daughter - Kerrie Matthews is intimately ...

There can be a heck of a lot of decisions to make during a round of golf. In this correspondent’s case, the decision to actually go out for a round of golf in the first place tends to be a ...

A few years after her sister’s type-one diabetes diagnosis, Sevanah Pantelis started developing the same symptoms.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...

New diabetes technologies are reshaping childhood for those with type 1 diabetes. These innovations bring greater freedom and safety but face affordability challenges in India.

DexCom reported revenues of $1.21 billion, up 21.6% year on year. This print exceeded analysts’ expectations by 2.5%. Overall, it was a strong quarter for the company with a solid beat of analysts’ ...

Medtronic plc offers stable dividends and consistent cash flow, but growth remains lackluster with revenues plateauing. Read ...

Insulet has launched a new campaign, “The Day Diabetes Showed Up to Work,” in honor of Diabetes Awareness Month in November.